Allspring Global Investments
CRMD icon

Allspring Global Investments’s CorMedix CRMD Stock Holding History

Allspring Global Investments’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-30,245
Closed -$368K – 1773
2025
Q4 		$368K Buy
30,245
+2,646
+10% +$29.3K ﹤0.01% 1463
2025
Q3 		$305K Buy
27,599
+13,632
+98% +$165K ﹤0.01% 1480
2025
Q2 		$165K Buy
+13,967
New +$154K ﹤0.01% 1558

Other funds holding CRMD

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Allspring Global Investments's CRMD Position: Q1 2026 in Review

Allspring Global Investments sold out of CorMedix (CRMD) in Q1 2026, closing a stake of 30,245 shares — an estimated $368K sold.

Allspring Global Investments first reported a position in CRMD in Q2 2025 and held it in 3 quarters. The position peaked at $368K in Q4 2025. 187 funds tracked by Wall St. Rank hold CRMD as of Q1 2026.

  • Allspring Global Investments reported no remaining CorMedix position as of Q1 2026 after selling out during the quarter.
  • Allspring Global Investments sold 30,245 CorMedix shares in Q1 2026, an estimated $368K.
  • Allspring Global Investments first reported a position in CorMedix in Q2 2025 and held it in 3 quarters.
  • Allspring Global Investments's CorMedix position peaked at $368K in Q4 2025.
  • 187 funds tracked by Wall St. Rank held CorMedix as of Q1 2026.

Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.